Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial [PDF]
Suthinee Rutnin +5 more
openalex +1 more source
Intralesional Measles-Mumps-Rubella Vaccine for Genital Warts: Report of two cases with a review of literature. [PDF]
Al-Qassabi AM, Al-Farsi F.
europepmc +1 more source
Using Locally Derived Seroprevalence Data on Measles, Mumps, Rubella, and Varicella by Birth Cohort to Determine Risks for Vaccine-Preventable Diseases During International Travel [PDF]
Gisela Rosario-Rosario +3 more
openalex +1 more source
Mumps vaccine effectiveness of a 3rd dose of measles, mumps, rubella vaccine in school settings during a mumps outbreak -- Arkansas, 2016-2017. [PDF]
Guo A +10 more
europepmc +1 more source
A phase II, III clinical trial to assess immunogenicity, reactogenicity and safety of the measles, rubella vaccine, produced by Bio-Manguinhos [PDF]
Eliane Carvalho dos Santos +9 more
openalex +1 more source
Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial. [PDF]
Baker B +6 more
europepmc +1 more source
Measles-rubella vaccine-associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child. [PDF]
Otiv M, Botre A, Shah P.
europepmc +1 more source
Estimated Current and Future Congenital Rubella Syndrome Incidence with and Without Rubella Vaccine Introduction - 19 Countries, 2019-2055. [PDF]
Lebo E +11 more
europepmc +1 more source

